7 Results for "

RETV804M/L

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "RETV804M/L" in MCE Product Catalog:

Cat. No.: HY-136534
CAS No.: 2414909-94-5
Purity:  98.22%
Target:  

RET

Research Areas:  

Cancer

RET V804M-IN-1 (compound 5) is a wt-RET -selective inhibitors of RETV804M kinase, with an IC50 of 20 nM .
loading...
    loading...
Cat. No.: HY-146710
CAS No.: 2259657-48-0
Target:  

RET

Research Areas:  

Cancer

RET-IN-16 is a potent and selective RET inhibitor with IC50s of 3.98 nM, 8.42 nM, 15.05 nM, 7.86 nM, 5.43 nM and 8.86 nM for RET(WT), RET(M918T), RET(V804L), RET(V804M), RET-CCDC6 and RET-KIF5B, respectively. RET-IN-16 has anticancer effects .
loading...
    loading...
Cat. No.: HY-153676
CAS No.: 2479961-46-9
Target:  

RET

Research Areas:  

Cancer

RET-IN-23 (compound 17) is a potent and orally active RET inhibitor with IC50 values of 1.32, 2.50, 6.54, 1.03, 1.47 nM for RET-WT, RET-CCDC6, RET-V804L, RET-V804M, RET-M918T, respectively. RET-IN-23 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-133553
CAS No.: 2414374-53-9
Purity:  99.51%
Target:  

RET

Research Areas:  

Cancer

RET-IN-3 (compound 34) is a selective RETV804M kinase inhibitor, with an IC50 of 19 nM .
loading...
    loading...
Cat. No.: HY-144030
CAS No.: 2684252-55-7
Target:  

RET

Research Areas:  

Others

RET-IN-12 (compound 2) is a RET inhibitor, with IC50 values of 0.3 nM and 1 nM for RET(WT) and RET(V804M), respectively .
loading...
    loading...
Cat. No.: HY-170019
CAS No.: 2479961-45-8
Target:  

RET

Research Areas:  

Cancer

RET-IN-28 (Compound 16) is a RET (transmembrane receptor tyrosine protein kinase) inhibitor. RET-IN-28 inhibits the activity of the mutant RET enzyme (RET-V804M), and can be applied to cancer research .
loading...
    loading...
Cat. No.: HY-149099
CAS No.: 2918281-79-3
Target:  

RET

Research Areas:  

Cancer

RET-IN-22 (compound 17b) is a potent, selective and orally active RET inhibitor with an IC50 of 20.9 nM and 18.3 nM for wild-type RET and RET-V804M, respectively. RET-IN-22 shows highly selective profile to most kinases, especially to EGFR and VEGFR2. RET-IN-22 has anticancer effects .
loading...
    loading...